Want to join the conversation?
$DVA 2Q15 Call: Our Kidney Care operating profits increased $38MM sequentially, driven primarily by 3 main positive factors. These positive factors were partially offset by higher dialysis pharmaceutical expenses, driven by higher average unit costs in the quarter and increased losses in our strategic initiatives in the international business.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.